Vnitr Lek 2017, 63(12):926-928 | DOI: 10.36290/vnl.2017.166

Může být "non-alcoholic fatty liver disease" nezávislým per se rizikovým faktorem mimojaterních onemocnění? - editorial

Jiří Ehrmann*, Vlastimil Procházka
II. interní klinika - gastro-enterologická a hepatologická LF UP a FN Olomouc

Received: August 17, 2017; Published: December 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ehrmann J, Procházka V. Může být "non-alcoholic fatty liver disease" nezávislým per se rizikovým faktorem mimojaterních onemocnění? - editorial. Vnitr Lek. 2017;63(12):926-928. doi: 10.36290/vnl.2017.166.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. EASL-EASD-EASO Clinical Practice Quidelines for the management of non-alcoholic fatty liver disease. J Hepatol 2016; 64(6): 1388-1402. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jhep.2015.11.004>. Go to PubMed...
    2. Angulo P. Long-term mortality in non-alcoholic fatty liver disease: is liver histology a fany prognostic significance? Hepatology 2010; 51(2): 373-375. Dostupné z DOI: <http://dx.doi.org/10.1002/hep.23521>. Erratum in Hepatology 2010; 51(5): 1868. Go to original source... Go to PubMed...
    3. Amstrong MJ, Adams LA, Syn WK et al. Extrahepatic complications of non-alcoholic fatty liver disease. Hepatology 2014; 59(3): 1174-1197. Dostupné z DOI: <http://dx.doi.org/10.1002/hep.26717>. Go to original source... Go to PubMed...
    4. Pais R, Giral P, Khan JF et al. Fatty liver is an independent predictor of early carotic atherosclerosis. J Hepatol 2016; 65(1): 95-102. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jhep.2016.02.023>. Go to original source... Go to PubMed...
    5. Siddiqui MS, Sterling RK, Kuketic VA et al. Association between high-normal levels of alanin aminotransferase and risk factors of atherogenesis. Gastroenterology 2013; 145(6): 1271-1279.e1-3. Dostupné z DOI: <http://dx.doi.org/10.1053/j.gastro.2013.08.036>. Go to original source... Go to PubMed...
    6. Targher G, Bertolini L, Rodella S et al. Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis. Clin J Am Soc Nephrol 2010; 5(12): 2166-2171. Dostupné z DOI: <http://dx.doi.org/10.2215/CJN.05050610>. Go to original source... Go to PubMed...
    7. Wong VW, Wong GL, Tsang SW et al. High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis. Gut 2011; 60(6): 829-836. Dostupné z DOI: <http://dx.doi.org/10.1136/gut.2011.237974>. Go to original source... Go to PubMed...
    8. Hwang ST, Cho YK, Park JH et al. Relationship of non-alcoholic fatty liver disease to colorectal adenomatous polyps. J Gastroenterol Hepatol 2010; 25(3): 562-567. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1440-1746.2009.06117.x>. Go to original source... Go to PubMed...
    9. Pagdala MR, Zein CO, Dasarathy S et al. Prevalence of hypothyreoidism in nonalcoholic fatty liver disease. Dig Dis Sci 2012; 57(2): 528-534. Dostupné z DOI: <http://dx.doi.org/10.1007/s10620-011-2006-2>. Go to original source... Go to PubMed...
    10. Brzowska MM, Ostapowicz G, Weltman MD. An association between non-alcoholic fatty liver disease and polycystic ovaria syndrome. J Gastroenterol Hepatol 2009; 24(2): 243-247. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1440-1746.2008.05740.x>. Go to original source... Go to PubMed...
    11. Musso G, Cassader M, Olivetti C et al. Association of obstructive sleep apnoea with the presence and severity of non-alcoholioc fatty liver disease. A systematic review and metaanalisis. Obes Rev 2013; 14(5): 417-431. Dostupné z DOI: <http://dx.doi.org/10.1111/obr.12020>. Go to original source... Go to PubMed...
    12. Ehrmann J, Aiglová K, Vrzalová D et al. Mimojaterní projevy NAFLD (non-alcoholic fatty liver disease). Jde o příčinnou souvislost? Interní Med 2017; 19(2): 72-77. Go to original source...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.